About Us
The concept behind PursueCare was developed through collaboration between experienced and entrepreneurial individuals from the behavioral health and pharmacy fields, and the technology industry. The PursueCare team shares a passion for revolutionizing how our country cares for individuals with substance use disorders and creating evidence-based solutions to more effectively address the opioid addiction and dependence.
Our mission is to knock down barriers to accessing high quality therapy and medication resources, preserving privacy and removing stigmas associated with seeking whole-person care and mental health treatment.
Questions You Should Be Asking
PursueCare is a new 24/7 on-demand and scheduled addiction counseling network accessible via a state-of-the-art telehealth app, bringing together qualified therapists with patients in need via video conferencing.
PursueCare provides access to care anywhere an addiction patient is located, reducing cost and hassle associated with conventional in-person trips to therapy and the pharmacy, improving the reach and quality of care, as well as adherence to medication-assisted addiction treatment programs.
PursueCare partners with an existing sterile specialty/compounding pharmacy licensed in 20 states, with the capability to provide addiction medications and non-opioid pain medications via mail-order.
You can fill out our contact form on the contact page or email us directly at: info@pursuecare.com.
PursueCare Leadership
Nicholas Mercadante, Esq.
Chief Executive Officer
Nick previously served as MedOptions’ President and COO. MedOptions is the largest provider of behavioral healthcare to LTC residents. Under his leadership MedOptions grew from a 150-provider regional operation, to 650 providers servicing 1500+ LTC facilities nationally, merging with the company’s largest competitor during that time. He helped integrate operating infrastructure post-merger, develop key client partnerships and relationships with payors, and strategically address operating challenges. Nick also led development of a telehealth program to serve facilities where traditional in-person staffing is challenging. Nick originally joined MedOptions as General Counsel and Vice President of Payor Relations.
Nick has extensive legal and operating experience in the healthcare industry. Prior to joining MedOptions, Nick operated a private law practice advising on corporate governance, growth strategies, acquisitions, and regulatory compliance. He has held roles as a litigation attorney and in litigation management for Chubb Insurance. He also worked in pharmacy business development. Nick graduated from Tulane Law School and is licensed to practice law in CT, NJ, and TX. He is a member of the the American College of Healthcare Executives, American Health Lawyers Association, the Health Care Compliance Association, the Association of Corporate Counsel, the CT Bar Association, and the TX Bar Association.
Thomas E. Menighan, BSPharm, MBA, ScD (Hon), FAPhA
Board of Directors
Tom is executive vice president and CEO of the American Pharmacists Association (APhA), the oldest and largest pharmacists’ advocacy and education association in America. He also serves on the board of the International Pharmaceutical Federation (FIP) and holds a number of board and leadership positions in broad pharmacy organization collaborations.
Previously, Tom was founder and president of SynTegra Solutions, Inc., which provides supply chain and chargeback auditing and consulting in risk management, 340B systems, anti-counterfeiting, and technology of medication. Menighan also founded SymRx, Inc., and developed CornerDrugstore.com. Other professional experiences include managing PharMark Corporation, creator of RationalMed, and licensor of systems for states to conduct drug utilization review for millions of state Medicaid enrollees. Tom also was a 20-year Medicine Shoppe owner in Huntington, West Virginia. He is a founder and current partner in Pharmacy Associates, Inc., a multistate sterile compounding and specialty pharmacy that is the predecessor company to CompreCareRx.